Cita APA (7a ed.)
Owen, T., Cole, I., Drygin, D., Valencia, T., Lee, E. C., Carlson, M., . . . Kamel, A. (2026). Pharmacokinetics, Safety, and Tolerability of Anti‐miR‐17 Oligonucleotide RGLS4326 in Healthy Adult Subjects. Journal of Clinical Pharmacology, 66(5), 1-17.
Cita Chicago Style (17a ed.)
Owen, Tate, et al. "Pharmacokinetics, Safety, and Tolerability of Anti‐miR‐17 Oligonucleotide RGLS4326 in Healthy Adult Subjects." Journal of Clinical Pharmacology 66, no. 5 (2026): 1-17.
Cita MLA (9a ed.)
Owen, Tate, et al. "Pharmacokinetics, Safety, and Tolerability of Anti‐miR‐17 Oligonucleotide RGLS4326 in Healthy Adult Subjects." Journal of Clinical Pharmacology, vol. 66, no. 5, 2026, pp. 1-17.
Precaución: Estas citas no son 100% exactas.